Clinical neuropathology practice guide 3-2013: levels of evidence and clinical utility of prognostic and predictive candidate brain tumor biomarkers
about
Management of elderly patients with gliomasKi-67/MIB-1 immunostaining in a cohort of human gliomas.Clinical Neuropathology practice news 2-2014: ATRX, a new candidate biomarker in gliomasMolecular diagnostics: techniques and recommendations for 1p/19q assessment.A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignanciesClinical Neuropathology practice news 1-2014: pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastoma.Brain Tumor Epidemiology - A Hub within Multidisciplinary Neuro-oncology. Report on the 15th Brain Tumor Epidemiology Consortium (BTEC) Annual Meeting, Vienna, 2014.Can MGMT promoter methylation status be used as a prognostic and predictive marker for glioblastoma multiforme at the present time? A word of caution.Higher levels of progranulin in cerebrospinal fluid of patients with lymphoma and carcinoma with CNS metastasis.Letter in response to David N. Louis et al, International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading, Brain Pathology, doi: 10.1111/bpa.12171.Application of brush cytology for FISH-based detection of 1p/19q codeletion in oligodendroglial tumors.Evaluation of the proliferation marker Ki-67 in gliomas: Interobserver variability and digital quantification.
P2860
Q34641001-13D2914E-9061-4D30-BADB-60CDF334D107Q35038363-C835DB83-7925-4402-9F0C-35408AC618D6Q38535798-E9F2F138-1573-43A4-BB5B-46F195F572A0Q38627124-1B89BC0D-2225-44DB-BF78-4575EEA266EBQ38977197-BED3104C-DE8F-4E08-8805-943012253CC8Q41870675-5BAE823D-1299-46EE-BAA0-AEF18F16A104Q43132659-AA652445-C8DA-412C-ABBC-85FDAC29140EQ45759866-1CF228E1-2DE5-47E1-8902-32D6C9030F47Q48229748-FA11ACD2-4B1C-43B4-9AE3-CC125F679E05Q48474932-22C60847-8514-4065-94CA-B21B806DAB35Q48626706-57CC4CF7-1A14-4E55-96CF-3B62FB44DB27Q55259357-B4E268B5-940B-42CC-8893-D74E985FA51F
P2860
Clinical neuropathology practice guide 3-2013: levels of evidence and clinical utility of prognostic and predictive candidate brain tumor biomarkers
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Clinical neuropathology practi ...... ndidate brain tumor biomarkers
@en
type
label
Clinical neuropathology practi ...... ndidate brain tumor biomarkers
@en
prefLabel
Clinical neuropathology practi ...... ndidate brain tumor biomarkers
@en
P2093
P2860
P356
P1476
Clinical neuropathology practi ...... ndidate brain tumor biomarkers
@en
P2093
Anna S Berghoff
Harald Heinzl
Harald Stefanits
Johannes A Hainfellner
Vienna Comprehensive Cancer Center Central Nervous System Unit
P2860
P304
P356
10.5414/NP300646
P577
2013-05-01T00:00:00Z